ClinicalTrials.Veeva

Menu

Hybrid PET/CT in Cancer Patients

R

Rambam Health Care Campus

Status

Completed

Conditions

Cancer

Treatments

Device: PET/CT imaging

Study type

Interventional

Funder types

Other

Identifiers

NCT00396916
hybridCTIL

Details and patient eligibility

About

The purpose of the present study is to assess the role of hybrid PET/CT imaging diagnosis of active malignancy in cancer patients with rising tumor markers after treatment and in the diagnosis of primary tumor in patients with metastatic cancer of unknown origin. The clinical impact of PET/CT in the management and treatment of these two groups of cancer patients will be evaluated

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Cancer patients in complete remission after treatment, with serial elevation of serum tumor markers and negative CT or other conventional imaging test.
  • Patients with newly diagnosed metastatic cancer with unknown primary tumor
  • Glucose levels below 150-200
  • Patient signed informed consent

Exclusion criteria

  • Pregnant or lactating women
  • Patient unable or not willing to tolerate the test until its completion
  • One or more of the inclusion criteria is not fulfilled

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems